RBM3 Inhibits the Cell Cycle of Cutaneous Squamous Cell Carcinoma through the PI3K/AKT Signaling Pathway.

Yan HuangWeichao SunDanli ZhuLi Liu Jian-Guo FengQian Yi

Published in: Current molecular pharmacology (2024)

This study provides novel insights into the suppressive roles of RBM3 in cell proliferation and the cell cycle in cSCC and highlights its therapeutic potential for cSCC.

Keyphrases

cell cycle
cell proliferation
squamous cell carcinoma
signaling pathway
pi k akt
lymph node metastasis
induced apoptosis